[6]. Siena S, et al. Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) Oncogene in Colorectal Cancer. Ann Oncol. 2018 May; 29(5):1108-1119. [7]. Yan M, et al. HER2 expression status in diverse cancers: review of results from 37,992 patients. Cancer Metastasis Rev. 201...
HER2 expression identifies dynamic functional states within circulating breast cancer cells. Jordan NV, Bardia A, Wittner BS, Benes C, Ligorio M, Zheng Y, Yu M, Sundaresan TK, Licausi JA, Desai R, O'Keefe RM, Ebright RY, Boukhali M, Sil S, Onozato ML, Iafrate AJ, Kapur R, Sgroi ...
[7] [6]Aileen I. Fernandez, Matthew Liu, Andrew Bellizzi, et al. Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue[J]. JAMA Oncol. 2022;8(4):1-4. [8] Modi, Shanu, Saura, et ...
4 Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y,Ozaki Y, et al. The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status. Breast Cancer 2022;2:234e41. https://doi.org/10.10...
Jang JS, Jang EJ, Park J. HER2 expression in breast cancer: Comparisons of fluorescence in situ hybridization and silver in situ hybridization, and immunohistochemical staining using monoclonal antibody and polyclonal antibody. Basic Appl Pathol 2010; 3: 115-20....
[2]Fernandez AI, Liu M, Bellizzi A, et al. Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue. JAMA Oncol. 2022 Feb 3:e217239. [3]Prat A, Modi S, Tsurutani JJ, et al. Determination of HER2-low status in tumors of patients with unresectable and/or metastatic br...
[1]Thaer Khoury, Rochelle Payne Ondracek, Song Yao, et al. HER2-Low Expression in Breast Cancer: Correlation with Histopathologic Variables in a Large Prospective Study. 2024USCAP. ABSTRACT 161. 审批编号:CN-147718 有效期...
[5]Mosele F, Deluche E, Lusque A, et al. Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial. Nat Med. 2023 Jul 24. [6]Bar Y, Dedeoglu A S, Fell G G, et al. Dynamic HER2-low status among patients with triple negative breast...
[1]Thaer Khoury, Rochelle Payne Ondracek, Song Yao, et al. HER2-Low Expression in Breast Cancer: Correlation with Histopathologic Variables in a Large Prospective Study. 2024USCAP. ABSTRACT 161. 审批编号:CN-147718 有效期至:2025-11-24 ...
[1] Duranti S, Fabi A, Filetti M, et al. Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers (Basel). 2021 Oct 16;13(20):5198. doi: 10.3390/cancers13205198. [2] Yan M, Schwaederle M, Arguello D, et al. HER2 expression status in diverse cancers: ...